Exhibit 99.1


                                                            Contact:
                                                            Investor Inquiries
                                                            Gregory C. Thompson
                                                            440-329-6111

                                                            Media Inquiries
                                                            Lara L. Mahoney
                                                            440-329-6393


NEWS RELEASE


CMS ANNOUNCES FINAL RULE TO IMPLEMENT DEFICIT REDUCTION ACT;  ENCOURAGES THE USE
OF NEW OXYGEN TECHNOLOGIES

     ELYRIA,  Ohio  (November  6, 2006) - On November  1, 2006,  the Centers for
Medicare & Medicaid Services (CMS) posted the final rule to implement oxygen and
capped rental  provisions of the Deficit  Reduction Act of 2005 (DRA). The final
rule  encourages  the  use of  new  oxygen  technologies  like  the  Invacare(R)
HomeFill(TM) Oxygen System.

     The final rule requires  medical  equipment  providers to transfer title of
oxygen  equipment to the  beneficiary  after 36 months for  equipment  placed in
service  after  January 2, 2006.  CMS also  established  a payment class for new
technology  such as portable oxygen  transfilling  equipment and portable oxygen
concentrators.  This class,  which  includes the HomeFill  Oxygen  System,  will
receive higher payments than traditional portable modalities.

     "The final rule of the DRA is  positive  for the  oxygen  patients  and the
industry that serves them. CMS has confirmed the  importance of new  technology,
and with the affirmation of the 36-month cap, providers have increased incentive
to purchase our HomeFill  Oxygen  System.  We're also pleased that CMS has given
oxygen patients the freedom to switch to new technology,  if they sign a patient
consent form. CMS obviously  wants to make it easier for patients to have access
to the best technology  available to them," said A. Malachi Mixon III,  chairman
and chief executive officer of Invacare.

     After the transfer of title to the patient, CMS will continue its policy of
paying for  "reasonable  and necessary"  maintenance  and service of beneficiary
owned equipment.  Specifically,  CMS will allow payments for general maintenance
and  servicing  visits every six months  beginning  six months  after  ownership
transfers to  beneficiaries.  Also, the provider who issued the equipment to the
patient will be responsible  for five years from the date of initial  service to
replace  equipment  that  does  not  last  for the  reasonable  useful  lifetime
established for the equipment under the Medicare program.





     "It is positive  that CMS  clarified  how it will handle  service of oxygen
equipment when the title transfers to the patient. This also emphasizes the need
for  providers  to invest in  reliable  and proven  equipment  in order to avoid
servicing or replacing equipment after 36 months," continued Mixon.

     Invacare  Corporation  (NYSE: IVC),  headquartered in Elyria,  Ohio, is the
global  leader  in the  manufacture  and  distribution  of  innovative  home and
long-term care medical products that promote recovery and active lifestyles. The
company has 5,900 associates and markets its products in 80 countries around the
world. For more information about the company and its products, visit Invacare's
website at www.invacare.com.

                                       ###